Although most clinical symptoms, serum biomarkers, and tumor markers did not reach statistical significance, patients in the IPF-LC group exhibited a higher prevalence of severe manifestations—such as persistent cough, weight loss, fatigue, and hemoptysis—compared with the IPF-only group.
← all excerpts
Retrospective analysis of the clinical features and prognosis of idiopathic pulmonary fibrosis combined with lung cancer.
1
—
—